Home›Companies›Biotech & Pharma›Metsera

Metsera, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 20, 2024·Suggest an edit

About Metsera

Metsera is a private company based in New York, New York, incorporated in 2022 in Delaware. It has reported $214,999,939 raised in one offering on Form D since November 2024. Its chief executive is Christopher Bernard.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 12, 2024Nov 20, 2024$214,999,939fully sold38$5.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Metsera's Form D filed Nov 20, 2024.

CV
Christopher Visioli
Executive officer
Also an executive officer at Areteia Therapeutics.
BH
Brian Hubbard
Executive officer
CB
Christopher Bernard
Chief Executive Officer and director
SM
Steven Marso
Executive officer
CM
PB
Paul Berns
Director
JP
Joshua Pinto
Director

Sources

  1. SECMetsera, Inc. filing history